Close Menu

Howard Goldstein has become senior vice president of sales and marketing, a newly created position, at Seattle-based Amnis. Most recently, he was senior vice president for sales, service, and marketing at Argonaut Technologies. In the past, he held sales and marketing positions at Incyte Genomics, Molecular Devices, Molecular Dynamics, and Applied Biosystems. Goldstein received an MBA from Temple University, an MS in biochemistry from the University of Dayton, and a BS in biology from Bucknell University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Nature News reports on the US National Science Foundation's investigations of undisclosed foreign ties among researchers it funds.

Researchers have developed a set of 10 principles to guide how a list of all species on earth should be put together, the Guardian reports.

Wired reports on a new firm developing a gene writing approach for therapeutic genome changes.

In Nature this week: a method called cis-X combines whole-genome and transcriptome sequencing data to identify regulatory noncoding variants, and more.